Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) are presenting a molecular imaging technique that allows oncologists to set patients» radiotherapy
doses right at that
critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital
organs.